Senior Director, Biologics R&D

USA - Smith & Nephew, Inc.

Columbia (MD)

Hybrid

USD 350,000 - 550,000

Full time

3 days ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

401k Matching Program
Discounted Stock Options
Tuition Reimbursement
Hybrid Work Model
Health Benefits

Job summary

Smith+Nebhew in the United States seeks a Senior Director, Biologics R&D to lead a global biologics development program. You will own the integrated plan, budgets, and governance, coordinating Clinical, Regulatory, CMC and Quality with external partners to drive Phase 2 readiness and regulatory strategy.

The role requires advanced life-science or engineering education, and a proven track record leading cross-functional teams in regulated environments.

Qualifications

  • Leadership of biologics development programs in regulated environments.
  • Cross-functional integration across Clinical, Regulatory, CMC, Quality and External partners.
  • Experience progressing drug/biologic programs through major milestones.

Responsibilities

  • Lead integrated biologics development program from early development through Phase 2 readiness.
  • Own budget, forecast, resources and governance with executive reporting.
  • Coordinate cross-functional teams and external partners to deliver on milestones.
  • Ensure regulatory and quality readiness and risk management throughout the program.

Skills

Strategic leadership
Cross-functional leadership
Budget management
Risk management
Executive communication
Matrix leadership
Program management
Biologics development

Education

Advanced degree in life sciences/engineering
PhD/MD/PharmD or equivalent

Job description

What will you be doing?
  • Lead the assigned biologics development program through the approved development scope and prepare evidence-based recommendations for subsequent investment gates.
  • Own the integrated development strategy and roadmap from early clinical development through Phase 2 readiness, pivotal-development planning, registration readiness and lifecycle options, subject to governance approval.
  • Integrate Clinical, Medical, Regulatory, CMC, Quality and Nonclinical strategies into one baselined plan with explicit assumptions, dependencies, decision gates and contingency paths.
  • Lead a matrixed team of Smith+Nebhew functional experts, shared services, external consultants, CROs, laboratories, collaborators and CDMOs.
  • Own program-level budget, forecast, resource plan, scenarios and cost discipline in partnership with Finance.
  • Provide clear recommendations to executive governance and escalated material safety, compliance, supply, regulatory, funding and schedule risks promptly.
  • Ensure consultants supplement capability rather than own Smith+Nebhew decisions; establish knowledge-transfer, documentation and exit requirements for every critical external role.
1. Integrated development leadership
  • Develop, maintain and execute the integrated development plan, milestones, critical path and risk-adjusted scenarios.
  • Lead cross-functional evaluation of clinical sequence, indication prioritization, evidence needs, manufacturing readiness and regulatory strategy.
  • Translate scientific, clinical and operational information into clear recommendations, trade-offs and investment decisions.
  • Align development choices with the target product profile, intended claims, patient needs, competitive context and value proposition.
2. Clinical and medical integration
  • Partner with the Medical Director and Clinical leadership to ensure qualified medical monitoring, participant-safety oversight, protocol strategy, dose and regimen decisions, and clinical-operational readiness.
  • Ensure early clinical outputs and unresolved evidence gaps become explicit Phase 2 entry criteria and regulatory questions.
  • Coordinate Clinical Operations, Biostatistics, Data Management and external study partners so execution, data quality and decision timelines remain aligned.
  • Maintain program oversight of safety, enrollment, product availability, study dependencies and inspection-ready documentation without superseding medical or clinical authority.
3. CMC, manufacturing and supply integration
  • Lead integrated governance of drug-substance and drug-product technology transfer, including contractual, technical, quality, regulatory, supply and budget dependencies.
  • Ensure the CMC plan addresses process knowledge, analytical methods, comparability, stability, specifications, control strategy, clinical supply, second-source optionality and registration readiness.
  • Coordinate internal technical stewards, Quality, Regulatory, Legal and external manufacturing partners against common stage gates and acceptance criteria.
  • Ensure agreement terms and execution plans preserve Smith+Nebhew access to data, methods, process know-how and future transfer options.
4. Regulatory, Quality and registration readiness
  • Partner with Regulatory to maintain the health-authority engagement plan, regulatory commitments, CMC impact assessments, submission roadmap and registration-readiness strategy.
  • Partner with Quality to ensure appropriate development quality systems, vendor qualification, quality agreements, audit readiness, deviation and CAPA governance, data integrity and inspection readiness.
  • Build registration readiness progressively through traceable decisions, controlled source documentation, submission-quality evidence and actively managed gaps.
  • Support planned transition from consultant‑led continuity to durable Smith+Nebhew Regulatory and Quality capability.
5. Governance, finance and executive communication
  • Prepare and lead weekly operating reviews and monthly executive governance materials, decisions, action logs and escalation follow‑up.
  • Own the integrated risk register, decision register, milestone baseline, resource assumptions and executive dashboard.
  • Partner with Finance to maintain accurate budgets, forecasts, capital versus OpEx inputs, commitments, contingencies and scenario‑based funding requirements.
  • Communicate progress, constraints, changes and recommendations with clarity, transparency and appropriate evidence.
6. Team and capability building
  • Build a high‑performing matrix team with clear role charters, decision rights, interfaces and accountability.
  • Mentor contributors and develop internal biologics‑development capability across functions.
  • Recommend the appropriate mix of permanent employees, shared functions and targeted external expertise.
  • Create a culture of patient focus, scientific rigor, quality, constructive challenge, accountability and timely escalation.
What will you need to be successful?
  • Approved integrated development plan with dated stage gates, owners, dependencies and decision criteria.
  • Qualified medical oversight and clinically sound study sequencing supported by documented evidence.
  • Executable technology‑transfer and supply plan with defined quality, regulatory and contractual acceptance criteria.
  • Clear health‑authority interaction and submission roadmap, with regulatory commitments and registration‑readiness gaps actively managed.
  • Accurate budget, forecast, cost‑center reporting and resource plan.
  • Timely executive decisions supported by concise, fact‑based recommendations.
  • Reduced critical‑person and consultant dependency through documented knowledge transfer and internal ownership.
  • On‑time closure of material risks, actions and governance commitments.
  • Advanced degree in a life‑science, pharmaceutical, engineering, medical or related discipline; PhD, PharmD, MD or equivalent advanced scientific degree preferred.
  • Substantial experience in pharmaceutical or biotechnology product development, including direct leadership of biologic or therapeutic programs in a regulated environment.
  • Demonstrated experience leading cross‑functional development teams across Clinical, Regulatory, CMC/Technical Operations, Quality and external partners.
  • Experience progressing at least one drug or biologic program through major development and regulatory milestones; direct Phase 2/3 and marketing‑application experience strongly preferred.
  • Working knowledge of IND development, GCP, GMP, biologics CMC, technology transfer, CDMO governance, clinical supply and health‑authority interactions.
  • Demonstrated ownership of budgets, integrated timelines, risk management, governance and executive decision support.
  • Experience operating successfully in a global corporate matrix and influencing senior functional leaders without relying solely on line authority.
  • Excellent written and verbal communication, with the ability to make complex scientific and operational issues clear to executives and technical teams.
  • Enterprise accountability: acts for the program and company rather than a single function.
  • Strategic judgment: distinguishes facts, assumptions and unresolved evidence and makes risk‑balanced recommendations.
  • Execution discipline: converts strategy into owners, milestones, budgets and closure criteria.
  • Matrix leadership: creates alignment across independent functions and external partners.
  • Courage and transparency: escalates risks early, challenges constructively and avoids false certainty.
  • Talent and capability building: internalizes knowledge and develops sustainable teams.
  • Patient and quality focus: places participant safety, product quality and regulatory integrity at the center of decisions.
Preferred experience
  • Topical biologics, enzymes, wound care, dermatology, burns, regenerative medicine or locally acting therapies.
  • Technology transfer involving microbial fermentation, protein or enzyme drug substance and topical drug product.
  • External‑manufacturing and CDMO partnerships, including comparability, validation, audits and inspection readiness.
  • Government‑funded or military clinical‑development collaborations.
  • Transitioning a consultant‑heavy or virtual biotechnology program into a larger corporate operating model.
  • Commercial, market‑access or portfolio exposure sufficient to connect development choices to value creation and lifecycle strategy.
Education
  • Bachelor's or Master's degree in Mechanical Engineering, Electrical Engineering, Biomedical Engineering, or a related engineering discipline.
Your Future:
  • 401k Matching Program
  • 401k Plus Program
  • Discounted Stock Options
  • Tuition Reimbursement Work/Life Balance: Flexible Personal/Vacation Time Off
  • Paid Holidays
  • Flex Holidays
  • Paid Community Service Day Your Wellbeing: Medical
  • Dental
  • Vision
  • Health Savings Account (Employer Contribution of $500+ annually)
  • Employee Assistance Program
  • Parental Leave
  • Fertility and Adoption Assistance Program Flexibility: Hybrid Work Model (For most professional roles)
  • Training: Hands‑On, Team‑Customized, Mentorship
  • Extra Perks: Discounts on fitness clubs, travel and more!
Inclusion + Belonging

Committed to Welcoming, Celebrating and Thriving. Learn more about our Employee Inclusion Groups on our website https://www.smith-nephew.com/

Smith+Nebhew provides equal employment opportunities to applicants and employees without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability.

Life Unlimited. At Smith+Nebhew we design and manufacture technology that takes the limits off living. The Senior Director, Biologics R&D is the single point of accountability for integrating and delivering a strategic biologics development program within Smith+Nebhew. The role converts enterprise strategy into an executable global development plan and leads a cross-functional team across Clinical, Medical, Regulatory, Chemistry Manufacturing & Controls (CMC), Quality, Non-clinical, Finance, Legal, external manufacturing partners and specialist consultants. The role owns program delivery, governance, budget, timeline, risks and decision quality while functional leaders retain authority for professional standards, regulated decisions and technical deliverables. The position does not replace the Medical Monitor, Regulatory authority, Quality authority or functional CMC owner. It provides the integrated leadership required to operate those accountabilities as one development program.

We Unlimited.

Life, culture, and benefits at S+N. Explore our website and learn more about our mission, our team, and the opportunities we offer. Smith+Nebhew is a global medical technology company. We design and manufacture technology that takes the limits off living. We support healthcare professionals to return their patients to health and mobility, helping them to perform at their fullest potential. From our first employee and founder, T.J. Smith, to our team today, it’s our people who make Smith+Nebhew a unique place. Yes, we love to innovate and develop exciting technologies, and we offer competitive salaries and progressive benefits. But it’s our culture - of Care, Collaboration and Courage - that really sets us apart. Through a spirit of ownership and can‑do attitude we work together to win. We’re a company of people who care about each other, about our customers and their patients, and about our communities. Together, we fulfill our shared purpose of Life Unlimited.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Senior Director, Wound Biologics R&D
Senior Director, Wound Biologics R&D

USA - Smith & Nephew, Inc. • United States

On-site
USD 230,000 - 300,000
401k Matching Program
Flexible time off / Work-Life Balance
Tuition Reimbursement
+1
Director, Change Management Lead
Director, Change Management Lead

GBR - Smith & Nephew UK Limited • United States

Hybrid
USD 158,000 - 235,000
Medical insurance
Dental coverage
Vision coverage
+7
Senior Medical Director
Senior Medical Director

Smith & Nephew • Fort Worth (TX)

Hybrid
USD 195,000 - 321,000
Medical, dental, vision coverage
401(k)
Tuition reimbursement
+6
District Manager, AWM Biologics (New York)
District Manager, AWM Biologics (New York)

Smith & Nephew • United States

On-site
USD 110,000 - 155,000
401k Matching Program
Tuition Reimbursement
Discounted Stock Options
+2
Director, SNOS Business Partner
Director, SNOS Business Partner

USA - Smith & Nephew, Inc. • United States

Hybrid
USD 150,000 - 223,000
Medical insurance
Dental insurance
Vision coverage
+3
Account Manager, Biologics (North West Philadelphia)
Account Manager, Biologics (North West Philadelphia)

Smith & Nephew • United States

Hybrid
USD 80,000 - 100,000
401k Matching Program
Tuition Reimbursement
Discounted Stock Options
+4
Senior Director, Wound Biologics R&D
Senior Director, Wound Biologics R&D

Smith & Nephew plc • Fort Worth (TX)

Hybrid
USD 260,000 - 400,000
401k Matching Program
Tuition Reimbursement
Hybrid Work Model
Account Manager - Biologics (Hackensack, NJ)
Account Manager - Biologics (Hackensack, NJ)

Smith & Nephew • United States

Hybrid
USD 80,000 - 100,000
Hybrid work model
Operations Manager
Operations Manager

Smith & Nephew • Phoenix (AZ)

On-site
USD 90,000 - 140,000
401k Matching Program
401k Plus Program
Discounted Stock Options
+1
Account Manager, Biologics (Northern Virginia)
Account Manager, Biologics (Northern Virginia)

Smith & Nephew • United States

Hybrid
USD 80,000 - 100,000
401k Matching Program
Tuition Reimbursement
Discounted Stock Options
+2